27th May 2020 Overnight Market Wrap

27th May 2020 Overnight Market Wrap

 Key Points

  • Novavax begins human trial for its Corona Virus vaccine
  • U.S. equities soar as confidence begins to move back into the market
  • Canadian Dollar down about 200 pips on a soft earnings report from Scotiabank

Bias: Risk on


U.S. equities did not start slowly after their long weekend, with stocks soaring on news that global economies are continuing to open up and on news that Novavax has started human trials for its Corona Virus vaccine. This brings a total of 10 drugs currently in clinical evaluation.

The Big Dollar was slightly weaker overnight, pressured by a move back into “risk on” currencies. The Canadian Dollar underperformed, falling as much as 200 pips after a soft earnings result from Scotiabank. Trade was largely scrappy and position adjustment led.

Oil prices rose slightly overnight amid news of continued production cuts, while gold eased amid the “risk on” bias.


Expect a quiet session in Asia today, with some profit taking expected after overnight moves and amid a lack of fresh data releases today. All that is on the slate of major note is U.S. Fed’s Beige Book.

Trade the global markets with a broker that has integrity, honesty and transparency at its core


This website is owned and operated by the Ox Securities group of companies, which include:
Ox Securities Pty Ltd registered address Level 37, 1 Macquarie Place, Sydney NSW 2000 Australia. AFSL 438402 ACN 163 551 602
Ox Securities Limited (SV) registered address Suite 305, Griffith Corporate Centre, Beachmont, Kingstown, St Vincent and the Grenadines
Risk Warning: The information contained on this website is general in nature and does not constitute advice or a recommendation to act upon the information or an offer. The information on this website does not take into account your personal objectives, circumstances, financial situations or needs. You are strongly recommended to seek independent professional advice before opening an account with us and/or acquiring our services/products. Ox Securities Limited (SV) do not accept applications from residents of the United States of America and Australia
Before you decide whether or not to invest any products referred to on this website, being over the counter (OTC) derivatives, it is important for you to read and consider our Financial Services Guide (FSG), Product Disclosure Statement (PDS), and Terms and Conditions (T&C), and ensure that you fully understand the risks involved. Fees, charges and commissions apply. OTC derivatives, including margin foreign exchange contracts and contract for differences, are leveraged products that carry a high level of risk to your capital. Trading is not suitable for everyone. You may incur losses that are substantially greater than your initial investment. You do not own, or have any rights to, the underlying assets which the OTC derivative is referring to. You should only trade with money you can afford to lose. There are also risks associated with online trading including, but not limited to, hardware and/or software failures, and disruptions to communication systems and internet connectivity.

Copyright © OxSecurities 2020. All rights reserved